US10844058 — Valbenazine salts and polymorphs thereof
Method of Use · Assigned to Neurocrine Biosciences Inc · Expires 2036-10-28 · 10y remaining
What this patent protects
This patent protects salts of the active substance valbenazine tosylate in various forms, and methods of using them to treat neurological disorders.
USPTO Abstract
Provided herein are salts of (S)-2-amino-3-methyl-butyric acid (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,l-a]isoquinolin-2-yl ester in amorphous and crystalline forms, and processes of preparation, and pharmaceutical compositions thereof. Also provided are methods of their use for treating, preventing, or ameliorating one or more symptoms of neurological disorders and diseases including hyperkinetic movement disorders or diseases.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1995 |
— | valbenazine-tosylate |
U-1995 |
— | valbenazine-tosylate |
U-3055 |
— | valbenazine-tosylate |
U-1995 |
— | valbenazine-tosylate |
U-3055 |
— | valbenazine-tosylate |
U-3055 |
— | valbenazine-tosylate |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.